- Author
-
S.J.L. Merat
- Title
- Protective antibody responses against HCV E1E2 in high-risk populations
- Supervisors
-
H. Spits
M.D. de Jong - Co-supervisors
-
C.J. Schinkel
T. Beaumont - Award date
- 31 October 2019
- Number of pages
- 194
- ISBN
- 9789463238083
- Document type
- PhD thesis
- Faculty
- Faculty of Medicine (AMC-UvA)
- Abstract
-
Hepatitis C is a global health problem with an estimate of 71 million chronically infected people worldwide in 2015. To reduce the global burden of hepatitis C virus (HCV), a new generation of treatments were developed. Despite the high efficacy of the therapies, the HCV epidemic continues to expand worldwide. Therefore, a vaccine against HCV is urgently needed. In order to design an effective vaccine, it is necessary to understand immune protection against this virus. It is well established that antibodies play critical roles in the immune response against viruses. However, little is known about the role of antibodies in spontaneous clearance of HCV infection and protection upon re-exposure. Therefore, we studied the antibody response specific for the HCV glycoproteins E1 and E2 in individuals protected against chronic HCV infection.
Our main finding is that a high frequency of B cells expressing cross-genotype specific antibodies was associated with spontaneous clearance of one or multiple infections. Interestingly, the cross-genotype specific antibodies were mainly directed against a particular epitope on E2, called AR3, and exhibited cross-neutralizing activity against different HCV genotypes. Moreover, we demonstrated that 25 years after clearance, AR3-specific B cells could be detected indicating that this antibody response can be long-lasting. Finally, we studied antibody responses in plasma of HCV individuals coinfected with human immunodeficiency virus (HIV). Although these individuals were HIV co-infected, some individuals could develop a broadly neutralizing antibody response against HCV during acute infection.
These observations should form the basis for developing an efficacious HCV vaccine. - Persistent Identifier
- https://hdl.handle.net/11245.1/79ffc322-b2c7-4def-acc0-dd20b6ae385c
- Downloads
-
Thesis (complete)
Front matter
Chapter 1: General introduction
Chapter 2: Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus
Chapter 3: Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance
Chapter 4: Hepatitis C virus broadly neutralizing monoclonal antibodies isolated 25 years after spontaneous clearance
Chapter 5: Development of broadly neutralizing antibody response against hepatitis C virus during acute HCV infection in HIV-infected men who have sex with men
Chapter 6: General discussion: The four dimensions of antibody response against HCV and their relevance for vaccine design
Summary; Samenvatting; List of authors and affiliations; Portfolio; Curriculum vitae; Acknowledgements
Propositions
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.